S100A8 and melanoma: Our findings revealed the number of S100A8/A9 expressing cells as a new powerful tissue biomarker, discriminating between non-metastasizing and metastasizing primary melanomas and between short-term and long-term survivors based on primary melanoma tissue and on metastatic tissue.